• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relapse of minimal change disease nephrotic syndrome after administering intravitreal bevacizumab.

作者信息

Pérez-Valdivia Miguel A, López-Mendoza Manuel, Toro-Prieto Francisco J, Cabello-Chaves Virginia, Toro-Ramos Mercedes, Martín-Herrera M Carmen, Gómez-García Luis

出版信息

Nefrologia. 2014 May 21;34(3):421-2. doi: 10.3265/Nefrologia.pre2014.Mar.12388.

DOI:10.3265/Nefrologia.pre2014.Mar.12388
PMID:24849064
Abstract
摘要

相似文献

1
Relapse of minimal change disease nephrotic syndrome after administering intravitreal bevacizumab.玻璃体内注射贝伐单抗后微小病变型肾病综合征复发
Nefrologia. 2014 May 21;34(3):421-2. doi: 10.3265/Nefrologia.pre2014.Mar.12388.
2
Relapse of minimal change nephrotic syndrome after intravitreal bevacizumab.玻璃体内注射贝伐单抗后微小病变肾病综合征复发
Pediatr Int. 2013 Jun;55(3):e46-8. doi: 10.1111/ped.12017.
3
Incidence of Charles Bonnet syndrome after intravitreal bevacizumab injection in neovascular age-related macular degeneration.玻璃体内注射贝伐单抗治疗新生血管性年龄相关性黄斑变性后查尔斯·博内综合征的发生率
Acta Ophthalmol. 2012 Dec;90(8):e647-8. doi: 10.1111/j.1755-3768.2012.02421.x. Epub 2012 Apr 10.
4
Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults.奥妥珠单抗对治疗成人频繁复发/依赖类固醇的微小病变病有效。
Nephrol Dial Transplant. 2024 Jul 31;39(8):1364-1367. doi: 10.1093/ndt/gfae061.
5
Steroid-responsive nephrotic syndrome due to minimal change nephropathy occurring while on captopril.
N Z Med J. 1987 Mar 25;100(820):187.
6
Retinal detachment after bevacizumab.贝伐单抗治疗后视网膜脱离
Ophthalmology. 2011 Nov;118(11):2304.e3-7. doi: 10.1016/j.ophtha.2011.05.015.
7
Osteonecrosis after administration of intravitreous bevacizumab.玻璃体内注射贝伐单抗后的骨坏死。
J Oral Maxillofac Surg. 2012 Mar;70(3):632-5. doi: 10.1016/j.joms.2011.02.104. Epub 2011 Jul 14.
8
[Minimal changes nephrotic syndrome associated to penicillamine treatment].
Nefrologia. 2004;24(2):183-7.
9
Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia.不同剂量玻璃体内注射贝伐单抗治疗病理性近视所致脉络膜新生血管。
Retina. 2011 May;31(5):880-6. doi: 10.1097/IAE.0b013e3181f2a293.
10
Nephrotic syndrome due to isolated minimal change glomerular disease in a patient taking pirprofen.
Clin Nephrol. 1986 Jun;25(6):314.

引用本文的文献

1
Evidence-Based Guidelines for Intravitreal Anti-VEGF Therapy for Diabetic Retinopathy in Chronic Kidney Disease.慢性肾脏病患者糖尿病视网膜病变玻璃体腔内抗VEGF治疗的循证指南
Diabetes Ther. 2025 Sep 11. doi: 10.1007/s13300-025-01791-y.
2
Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry.玻璃体内血管内皮生长因子抑制剂全身及肾脏毒性登记处。
Clin Kidney J. 2025 Jun 27;18(8):sfaf206. doi: 10.1093/ckj/sfaf206. eCollection 2025 Aug.
3
Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus.
玻璃体内抗血管内皮生长因子药物对糖尿病患者肾功能的影响。
Kidney Int Rep. 2024 Feb 9;9(5):1397-1405. doi: 10.1016/j.ekir.2024.02.003. eCollection 2024 May.
4
Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study.玻璃体内抗血管内皮生长因子药物会导致肾脏不良事件吗？一项药物警戒性真实世界研究。
Front Med (Lausanne). 2023 Feb 14;10:1100397. doi: 10.3389/fmed.2023.1100397. eCollection 2023.
5
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study.基于匹配研究，玻璃体内注射血管内皮生长因子抑制剂不会增加经活检证实的糖尿病肾病患者终末期肾病的风险。
Front Pharmacol. 2022 Dec 7;13:1077047. doi: 10.3389/fphar.2022.1077047. eCollection 2022.
6
Progression of diabetic nephropathy after successful pancreas transplantation alone: a case report.单纯胰腺移植成功后糖尿病肾病的进展：一例报告
Korean J Transplant. 2019 Dec 31;33(4):146-152. doi: 10.4285/jkstn.2019.33.4.146.
7
Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration.玻璃体内血管内皮生长因子抑制剂毒性的综述及1例年龄相关性黄斑变性患者并发血栓性微血管病的塌陷型局灶节段性肾小球硬化病例报告。
Clin Kidney J. 2021 Mar 23;14(10):2158-2165. doi: 10.1093/ckj/sfab066. eCollection 2021 Oct.
8
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy.糖尿病性增殖性视网膜病变玻璃体腔内注射血管内皮生长因子阻滞剂后蛋白尿和肾功能恶化
Clin Kidney J. 2020 Jun 28;13(6):969-980. doi: 10.1093/ckj/sfaa049. eCollection 2020 Dec.
9
Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use.玻璃体内注射血管内皮生长因子抑制剂后诱发的血栓性微血管病和急性肾损伤 玻璃体内使用后与VEGF阻断相关的血栓性微血管病
Front Med (Lausanne). 2020 Oct 7;7:579603. doi: 10.3389/fmed.2020.579603. eCollection 2020.
10
Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension.三名接受玻璃体内血管内皮生长因子抑制剂注射治疗的患者，随后出现慢性蛋白尿和高血压加重的情况。
Clin Kidney J. 2019 Feb;12(1):92-100. doi: 10.1093/ckj/sfy060. Epub 2018 Jul 27.